"Regenerative Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.
| Descriptor ID |
D044968
|
| MeSH Number(s) |
H02.403.750
|
| Concept/Terms |
Regenerative Medicine- Regenerative Medicine
- Medicine, Regenerative
- Medicines, Regenerative
- Regenerative Medicines
|
Below are MeSH descriptors whose meaning is more general than "Regenerative Medicine".
Below are MeSH descriptors whose meaning is more specific than "Regenerative Medicine".
This graph shows the total number of publications written about "Regenerative Medicine" by people in this website by year, and whether "Regenerative Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 2 | 3 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 2 | 5 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 3 | 6 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Regenerative Medicine" by people in Profiles.
-
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023 09; 25(9):920-929.
-
Actuation enhances patterning in human neural tube organoids. Nat Commun. 2021 05 27; 12(1):3192.
-
Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves? EMBO J. 2019 10 01; 38(19):e103148.
-
GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib. Drug Res (Stuttg). 2018 Aug; 68(8):436-443.
-
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell. 2012 May 04; 10(5):570-82.
-
Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010 Dec; 16(12):1400-6.
-
Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev. 2009 Jun; 61(1):1-13.
-
Mesenchymal stem cells in regenerative medicine: of hopes and challenges. Medscape J Med. 2009; 11(1):28.